Short-term exposure to several different types of air pollution was found to significantly increase disease severity in patients with chronic rhinosinusitis with nasal polyps.
Exposure to air pollution may significantly increase disease severity in patients with chronic rhinosinusitis (CRS) with nasal polyps, according to study findings published in The Laryngoscope.
In examining potential contributors to the pathophysiology of CRS, air pollution has been identified across numerous studies to be an important environmental risk factor. Although patients with CRS with nasal polyps (CRSwNP) generally have more severe symptoms and higher recurrence rates vs those with CRS without NP, researchers noted that studies investigating the adverse effects of air pollution on this patient population remain limited.
They conducted a retrospective cohort study of patient data derived from monitoring sites in Beijing, China to assess individual exposure to 5 types of air pollution:
“China, which has the largest number of patients with CRS worldwide, has experienced serious air pollution problems in recent years,” said researchers. “However, no study has focused on the association for air pollution and CRSwNP in the Chinese population.”
Participants with CRSwNP (n = 282; mean age, 44.7 years; 65.60% male) were assessed for several outcome measures, including the Lund-Mackay (L-M) score, Lund-Kennedy (L-K) score, visual analogue scale (VAS) score, and nasal patency/airflow resistance to analyze correlations with air pollution and compare groups with different exposure types.
Researchers also examined potential air pollution risk factors of the endotype of eosinophilic CRSwNP (ECRSwNP) via multivariable-adjusted binary logistic regression.
Among those with CRSwNP, the individual average 30 day concentration of PM2.5 was 69.93 μg/m3, which exceeded the health criterion of Chinese Ambient Air Quality Standards. After assessing the 30-day average concentration of air pollution, researchers said that short-term exposures to PM2.5/10, SO2, CO, NO2, and O3 were weak but significantly associated with increased L-M scores (P < .05).
“The L-M scores of the group of the highest PM2.5 (≥ 150 μg/m3) exposure were significantly higher than those of the control group.”
Moreover, short-term exposures to PM10, CO, and NO2 were correlated with increased VAS headache/facial pain scores (P < .01). Regarding the CRSwNP cellular endotype, each increased unit of the average concentration of PM2.5 was associated with a 1.047-fold (95% CI, 1.005-1.091; P = .0293) increas ed risk of the endotype of ECRSwNP.
In concluding, researchers said that additional multi-center studies with large sample sizes are warranted to further elucidate the role of environmental exposures in CRS pathophysiology and patient outcomes.
“Air pollution exposure exacerbated CRSwNP severity and PM2.5 could be a risk factor for endotype of ECRSwNP, suggesting the role of air pollution in CRSwNP pathogenesis.”
Reference
Yang X, Shen S, Deng Y, Wang C, and Zhang L. Air pollution exposure affects severity and cellular endotype of chronic rhinosinusitis with nasal polyps. Laryngoscope. Published online December 6, 2021. doi:10.1002/lary.29974
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
Following Roe v Wade Overturn, Research Focuses on Male Contraceptives
May 6th 2024Stephanie T. Page, MD, PhD, UW Medicine Diabetes Institute, presented on ongoing research and growing interest in new male contraceptive options, such as an oral pill and a hormonal transdermal gel, at the American Urological Association 2024 Annual Meeting.
Read More